Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1592-1597

  Martinez, Jennifer ^a   Huang, Xiaopei ^a   Yang, Yiping ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CELL STRAIN L 929; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VACCINIA; VACCINIA VIRUS; VIRUS INHIBITION; VIRUS VIRULENCE; ANIMAL; DRUG EFFECT; IMMUNOLOGY; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; IMMUNITY, NATURAL; INTERFERON TYPE I; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, MUTANT STRAINS; VACCINIA;

EID: 40749093670     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1592     Document Type: Article

References (29)

1. Moss, B. 2001. Poxviridae: the viruses and their replication. In Fields Virology, Vol. 2. D. M. Knipe and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, pp. 2849-2883.
2. Fenner, F., D. Henderson, I. Arita, Z. Jezek, and I. Ladnyi. 1988. Small-pox and Its Eradication. World Health Organization, Geneva p. 1460.
3. Lane, H. C., J. L. Montagne, and A. S. Fauci. 2001. Bioterrorism: a clear and present danger. Nat. Med. 7: 1271-1273.
4. Cohen, J. 2001. Bioterrorism: smallpox vaccinations: how much protection remains? Science 294: 985.
5. Smith, G. L., and G. McFadden. 2002. Smallpox: anything to declare? Nat. Rev. Immunol. 2: 521-527.
6. Baxby, D. 1991. Safety of recombinant vaccinia vaccines. Lancet 337: 913.
7. Bray, M., and M. E. Wright. 2003. Progressive vaccinia. Clin. Infect. Dis. 36: 766-774.
8. Booss, J., and L. E. Davis. 2003. Smallpox and smallpox vaccination: neurological implications. Neurology 60: 1241-1245.
9. French, A. R., and W. M. Yokoyama. 2003. Natural killer cells and viral infections. Curr. Opin. Immunol. 15: 45-51.
10. Bukowski, J. F., B. A. Woda, S. Habu, K. Okumura, and R. M. Welsh. 1983. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131: 1531-1538.
11. Dokun, A. O., S. Kim, H. R. Smith, H. S. Kang, D. T. Chu, and W. M. Yokoyama. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2: 951-956.
12. Chisholm, S. E., and H. T. Reyburn. 2006. Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J. Virol. 80: 2225-2233.
13. Parker, A. K., S. Parker, W. M. Yokoyama, J. A. Corbett, and R. M. Buller. 2007. Induction of natural killer cell responses by ectromelia virus controls infection. J. Virol. 81: 4070-4079.
14. Garcia-Sastre, A., and C. A. Biron. 2006. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312: 879-882.
15. Pestka, S., C. D. Krause, and M. R. Walter. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202: 8-32.
16. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
17. van den Broek, M. F., U. Muller, S. Huang, R. M. Zinkernagel, and M. Aguet. 1995. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148: 5-18.
18. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
19. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517.
20. Zhu, J., J. Martinez, X. Huang, and Y. Yang. 2007. Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-β. Blood 109: 619-625.
21. Ilyinskii, P. O., R. Wang, S. P. Balk, and M. A. Exley. 2006. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo. J. Virol. 80: 7146-7158.
22. Zompi, S., J. A. Hamerman, K. Ogasawara, E. Schweighoffer, V. L. Tybulewicz, J. P. Di Santo, L. L. Lanier, and F. Colucci. 2003. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat. Immunol. 4: 565-572.
23. Andoniou, C. E., S. L. van Dommelen, V. Voigt, D. M. Andrews, G. Brizard, C. Asselin-Paturel, T. Delale, K. J. Stacey, G. Trinchieri, and M. A. Degli-Esposti. 2005. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 6: 1011-1019.
24. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1: 433-442.
25. Huarte, E., E. Larrea, R. Hernandez-Alcoceba, C. Alfaro, O. Murillo, A. Arina, I. Tirapu, A. Azpilicueta, S. Hervas-Stubbs, S. Bortolanza, et al. 2006. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication. Mol. Ther. 14: 129-138.
26. Bukowski, J. F., K. W. McIntyre, H. Yang, and R. M. Welsh. 1987. Natural killer cells are not required for interferon-mediated prophylaxis against vaccinia or murine cytomegalovirus infections. J. Gen. Virol. 68: 2219-2222.
27. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
28. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
29. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-α β, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279-4287.